Company Filing History:
1 out of 1 
1 out of 80 Years Active: 2001
Title: The Innovations of Greta A. Gottardy
Introduction
Greta A. Gottardy, an accomplished inventor based in Lansdale, PA, has made significant contributions to the field of nanoparticle technology. With a solid track record of two patents, her work focuses on enhancing the stability and effectiveness of nanoparticulate compositions.
Latest Patents
Gottardy's latest innovations include two pivotal patents. The first patent addresses the "Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions." This invention describes nanoparticulate compositions that consist of insoluble organic drugs, with polyethylene glycol-derivatized lipids adsorbed on the drug's surface. The lipids can take forms such as PEG-phospholipid, PEG-cholesterol, PEG-cholesterol derivative, PEG-vitamin A, or PEG-vitamin E, achieving an effective average particle size of less than about 1 micron. The patent also encompasses methods for making and utilizing these compositions.
The second patent focuses on "Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions." This invention outlines techniques to reduce nanoparticulate compositions to an optimal effective average particle size, which leads to prolonged particle size stability and minimal crystal growth, even under elevated temperature conditions.
Career Highlights
Throughout her career, Greta has worked for notable companies in the pharmaceutical field, including Klan Pharma International Ltd. and Elan Pharma International Limited. Her role in these organizations has allowed her to refine her expertise in nanoparticle technology and contribute to the advancement of drug delivery systems.
Collaborations
In her journey as an inventor, Greta has collaborated with talented individuals such as Elaine Liversidge and Linden Wei. These partnerships have played a significant role in the development of her innovative ideas and patents.
Conclusion
Greta A. Gottardy represents the forefront of innovation in nanoparticle technology. With her impressive track record of patents and extensive industry experience, she continues to inspire new approaches in the field, making significant strides toward improving drug formulations and delivery systems. Her dedication and expertise exemplify the spirit of innovation that drives advancements in modern medicine.